ABSTRACT
The role of IL-1 and TNF in the pathogenesis of RA and other chronic inflammatory diseases that lead to tissue destruction is well established at present. However, despite the strong synergism between the two molecules, some differences – if only of a quantitative nature – may be important, whether they are linked to the subtype of patients, or stage of disease, or type of clinical symptoms (Figure 7.1).
